Sensyne Health, Phesi: 60m patient research dataset
Clinical AI company Sensyne Health has reached the milestone of building its dataset of clinical research, trial, and de-identified and anonymized data to more than 60m patients. The milestone reportedly was made possible by the company’s investment in virtual clinical development firm Phesi, and progress made by both firm in building their respective data platforms.
Sensyne Health CEO Paul Drayson said, “60m patients is an important milestone in our journey to create the world’s best data resource for medical research. However, it is the quality and depth of the data across many disease areas and the combination of both clinical research data, clinical trials data and longitudinal real world data from electronic patient records, that makes the database such a powerful tool for research professionals in both the life sciences and healthcare sectors.”